TransCode Therapeutics (RNAZ) Expected to Announce Quarterly Earnings on Wednesday
TransCode Therapeutics (NASDAQ:RNAZ – Get Free Report) is anticipated to announce its Q1 2025 earnings results before the market opens on Wednesday, May 21st. Analysts expect the company to announce earnings of ($2.00) per share and revenue of $0.30 million for the quarter. TransCode Therapeutics Stock Performance RNAZ opened at $0.35 on Wednesday. The company’s […]
